Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 227 to 276 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
114\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein c. [source:refseq;acc:nm\_012272]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4300.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5807.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.35048\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
115\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
116\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
117\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
necdin. [source:swissprot;acc:q99608]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5136.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6895.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34247\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-b. [source:swissprot;acc:p17275]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5579.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7488.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3422\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5140.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6893.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34112\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33503\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
126\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
24250\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18164.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33499\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
127\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-d. [source:swissprot;acc:p17535]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7523.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33436\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
128\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
luc7-like 2; cgi-74 protein; cgi-59 protein. [source:refseq;acc:nm\_016019]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4355.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5810.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3341\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
129\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
luc7-like; sarcoplasmic reticulum protein luc7b1. [source:refseq;acc:nm\_018032]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4358.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5811.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33348\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
130\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box p4; fork head-related protein like a; winged-helix repressor foxp4. [source:refseq;acc:nm\_138457]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2234.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2978.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33287\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d2 (mage-d2 antigen) (breast cancer associated gene 1 protein) (bcg-1) (11b6) (hepatocellular carcinoma associated protein jcl-1). [source:swissprot;acc:q9unf1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
131\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein p1 (hspc215). [source:swissprot;acc:q9h334]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2234.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2978.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33285\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trophinin. [source:swissprot;acc:q12816]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
132\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5948.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5441.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09318\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein p3 (zinc finger protein jm2) (scurfin). [source:swissprot;acc:q9bzs1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2236.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2980.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33253\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
133\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
23421.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17580.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33225\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7662.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09265\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
134\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6670.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7286.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09242\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.32626\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
135\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7248.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7916.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09226\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
136\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase, 52kda, polypeptide 1; ribosomal protein s6 kinase, 52kd, polypeptide 1. [source:refseq;acc:nm\_012424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7020.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7667.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09214\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
137\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-box transcription factor tbx19 (t-box protein 19). [source:swissprot;acc:o60806]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6139.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6699.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09121\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
138\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6709\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7313.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09008\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kv channel interacting protein 1; vesicle apc-binding protein; a-type potassium channel modulatory protein 1. [source:refseq;acc:nm\_014592]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2755.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2094.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31555\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/